Indibulin
CAS: 204205-90-3
Ref. 3D-EIA20590
| 1g | 740.00 € | ||
| 50mg | 172.00 € | ||
| 100mg | 248.00 € | ||
| 250mg | 364.00 € | ||
| 500mg | 517.00 € |
Product Information
- 2-(1-(4-Chlorophenylmethyl)-1H-indol-3-yl)-2-oxo-N-(pyridin-4-yl)acetamide
- 2-[1-(4-chlorobenzyl)-1H-indol-3-yl]-2-oxo-N-(pyridin-4-yl)acetamide
Indibulin is a potent antitumor agent that inhibits the assembly of tubulin. It has been shown to have significant cytotoxicity against prostate cancer cells and potent antiangiogenic properties. Indibulin has been shown to inhibit the production of epidermal growth factor, which is involved in tumor angiogenesis, by binding to the epidermal growth factor receptor. Indibulin also binds to excipients, such as mannitol and lactose, forming a granulate for intravenous injection. This drug has been shown to have pharmacokinetic properties in vitro and in vivo studies.
Chemical properties
Technical inquiry about: 3D-EIA20590 Indibulin
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
